ATC codes:
R01AA07
EMLc
Indication
Nasal congestion
ICD11 code:
MF11.7
INN
Xylometazoline
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Local > Nasal > Spray:
0.05% equivalent to 0.5 mg per mL
(EMLc)
Local > Nasal > Drops: 0.05% equivalent to 0.5 mg per mL (EMLc)
Local > Nasal > Drops: 0.05% equivalent to 0.5 mg per mL (EMLc)
EML status history
Sex
All
Age
Children (1 month - 12 years)
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives to be reviewed
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of xylometazoline nasal drops 0.05%;
- removal of the note regarding use in children less than 3 months.